PD-L1 expression is the most important biomarker for response to immunotherapy in advanced metastatic NSCLC. In this webinar, the development and validation of our supervised algorithm for PD-L1 scoring are discussed.
On-demand Webinar Development and validation of a deep learning AI model in lung cancer
Speakers
Liesbeth Hondelink Department of Pathology, Leiden University Medical Center